BioWorld MedTech

March 2, 2011

Deals roundup: Daiichi Sankyo to acquire Plexxikon for nearly $930M

A merger agreement between Daiichi Sakyo (Tokyo) and Plexxikon (Berkeley, California) just shy of $1 billion could lead to better personalized treatments for melanoma patients. (Medical Device Daily) Read More

FDA clears Valeritas' V-Go disposable insulin device

Financings roundup: Medtronic, investors to put $31.4 million into Tengion

Washington roundup: FDA warns surgical instrument maker for unapproved claims

Agreements/contracts: PatientPoint to access MZI's EZ-Cap technology

MDD's food for med-tech thought

Court Report: Align files patent infringement suit against rival ClearCorrect

HIT roundup: HealthFirst TPA launches VIIAD products into its offerings

Grants roundup: OZ to provide newborn screening to TEHDI

Product Briefs

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for April 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for April 9, 2025.

Many med-tech company supply chains protected from tariffs

BioWorld MedTech

In the wake of the pandemic, many leading med-tech companies took steps to on-shore and near-shore manufacturing, a move that could protect significant numbers of...

Caution tape displaying US flag, tariffs

Biopharma exempt from US reciprocal tariffs, but not untouched

BioWorld

At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...

Many US tariffs paused, pharma warned, EU put on notice

BioWorld

The on-again, off-again U.S. tariffs are off again, at least for now, for more than 75 countries that have reached out to the Trump administration to negotiate...